- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canopy Rivers reaches the TSX and becomes the latest marijuana company to obtain a senior Canadian listing.
Canopy Rivers (TSX:RIV,OTC Pink:CNPOF) became the most recent in a growing number of cannabis companies to list on the Canadian senior exchange.
Despite the company’s uplisting to the Toronto Stock Exchange (TSX), shares for the cannabis investment firm declined on Monday (September 9) nearly 2 percent for a closing price of C$2.48.
The listing comes less than a year after Canopy River’s initial public transaction on the sibling venture exchange. Shares of the company started trading on the TSX normally today.
The listing also comes less than a month after the Ontario-based cannabis company first received conditional approval to move from the TSX Venture Exchange and list its class A subordinate voting shares on the TSX.
In a press release, Canopy Rivers CEO Narbe Alexandrian said a TSX listing will offer enhanced liquidity to shareholders.
Canopy Rivers, the investment arm of cannabis giant Canopy Growth (NYSE:CGC,TSX:WEED), was recently lauded by CIBC Capital Markets research analyst John Zamparo after releasing results for its first quarter of 2020.
The analyst rated the company as an “outperformer” and noted the stock was undervalued, though the company reported a loss of C$2.9 million in its most recent quarter, and expects to keep seeing these quarterly losses.
Canopy Rivers has been making strides to establish itself as a venture capital investor. During a panel at the MJBizConINTL in Toronto, Alexandrian said in the last 365 days, the firm has heard from over 1500 entrepreneurs to get a sense of the general cannabis market.
In a panel about raising capital, Narbe Alexandrian, CEO of $RIV, says their thesis is that vertical integration doesn’t work, unless a company has a massive cash balance. #MJBizConINTL
— Cannabis News | INN (@INN_Cannabis) September 6, 2019
Canopy Rivers works with Canopy Growth to identify strategic partnerships and makes investments to help bolster those partners and grow its overall portfolio.
Alexandrian explained he wants to see more targeted approaches from cannabis companies, rather than a one-size fits all business model.
The executive was critical of the stock market adding gone are the days of hype and promotion for cannabis companies, instead investors are only interested in results.
Alexandrian added that now, the struggle for Canopy Rivers is dealing with companies that have little capital but big plans that include multi-industry integration. He said that for small to midsize companies, the best plan of action is to narrow their focus to a few key capabilities and outsource other tasks.
Canopy Rivers joins Delta 9 Cannabis (TSX:DN,OTCQX:VRNDF) as one of the most recent cannabis stocks on the TSX. The Manitoba-based cannabis producer announced in August that it began trading its shares on the TSX last week.
Analyst consensus on TipRanks of Canopy Rivers has the stock listed as a “Strong Buy” with a price target of C$6.58.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.